Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix

被引:15
作者
O'Sullivan, MJ
Rader, JS
Gerhard, DS
Li, Y
Trinkaus, KM
Gersell, DJ
Huettner, PC
机构
[1] Washington Univ, Med Ctr, Lauren V Ackerman Lab Surg Pathol, Dept Obstet & Gynecol, St Louis, MO 63110 USA
[2] Washington Univ, Med Ctr, Dept Genet, St Louis, MO 63110 USA
[3] Washington Univ, Med Ctr, Dept Biostat, St Louis, MO 63110 USA
关键词
loss of heterozygosity; cervical cancer; allelotyping; metastasis; recurrence;
D O I
10.1053/hupa.2001.24317
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We have previously demonstrated a strong relationship between loss of heterozygosity (LOH) at chromosome 11q23.3 and the presence of extensive tumor plugs in lymphvascular spaces (LVS) in stage 1B cervical carcinoma, suggesting that genes at this locus may regulate vasculoinvasion, This study examined LOH at 11q23.3 in microdissected tumor plugs within LVS and in metastatic foci in lymph nodes (MFLN), as well as corresponding invasive tumor and adjacent cervical intraepithelial neoplasia (CIN) 3 in stage 1B squamous fell carcinoma. Of 49 invasive carcinomas, 38.8% had LOH at 11q23.3, Of 36 tumor plugs in LVS, 39% had LOH at 11q23.3. Twenty percent of 15 MFLN demonstrated LOH at 11q23.3. Patients with LOH at 11q23.3 are significantly more likely to have disease recurrence than patients without LOH at 11q23.3 (P = .02). Of 10 foci of CIN 3, none showed LOH at 11q23.3. Although unlikely to have an impact early in carcinogenesis, tumor-suppressor genes located in the region of 11q23.3 appear to be important in tumor progression, facilitating lymphvascular space invasion and, by inference, spread to lymph nodes in squamous cell carcinoma of the cervix. Copyright (C) 2001 by W.B, Saunders Company.
引用
收藏
页码:475 / 478
页数:4
相关论文
共 34 条
[1]  
Baffa R, 1996, CANCER RES, V56, P268
[2]   LOSS OF HETEROZYGOSITY OCCURS AT THE D11S29 LOCUS ON CHROMOSOME 11Q23 IN INVASIVE CERVICAL-CARCINOMA [J].
BETHWAITE, PB ;
KORETH, J ;
HERRINGTON, CS ;
MCGEE, JOD .
BRITISH JOURNAL OF CANCER, 1995, 71 (04) :814-818
[3]   Cell sampling - Laser capture microdissection: Molecular analysis of tissue [J].
Bonner, RF ;
EmmertBuck, M ;
Cole, K ;
Pohida, T ;
Chuaqui, R ;
Goldstein, S ;
Liotta, LA .
SCIENCE, 1997, 278 (5342) :1481-&
[4]  
CHEN CS, 1993, BLOOD, V81, P2386
[5]  
Dahiya R, 1997, INT J CANCER, V72, P283, DOI 10.1002/(SICI)1097-0215(19970717)72:2<283::AID-IJC14>3.0.CO
[6]  
2-H
[7]   CELLULAR ONCOGENES AND SUPPRESSOR GENES AS PROGNOSTIC MARKERS IN CANCER [J].
DUFFY, MJ .
CLINICAL BIOCHEMISTRY, 1993, 26 (06) :439-447
[8]   Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia [J].
Evans, MF ;
Koreth, J ;
Bakkenist, CJ ;
Herrington, CS ;
McGee, JOD .
ONCOGENE, 1998, 16 (19) :2557-2564
[9]   Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas [J].
Guo, C ;
White, PS ;
Weiss, MJ ;
Hogarty, MD ;
Thompson, PM ;
Stram, DO ;
Gerbing, R ;
Matthay, KK ;
Seeger, RC ;
Brodeur, GM ;
Maris, JM .
ONCOGENE, 1999, 18 (35) :4948-4957
[10]   LOSS OF HETEROZYGOSITY IN CERVICAL-CARCINOMA - SUBCHROMOSOMAL LOCALIZATION OF A PUTATIVE TUMOR-SUPPRESSOR GENE TO CHROMOSOME 11Q22-Q24 [J].
HAMPTON, GM ;
PENNY, LA ;
BAERGEN, RN ;
LARSON, A ;
BREWER, C ;
LIAO, S ;
BUSBYEARLE, RMC ;
WILLIAMS, AWR ;
STEEL, CM ;
BIRD, CC ;
STANBRIDGE, EJ ;
EVANS, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :6953-6957